ORIC Pharmaceuticals Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 66
Employees
  • Stock Symbol
  • ORIC
Stock Symbol
  • Share Price
  • $16.61
  • (As of Monday Closing)

ORIC Pharmaceuticals General Information

Description

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 240 East Grand Avenue
  • 2nd Floor
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

ORIC Pharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ORIC Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.61 $16.65 $15.96 - $40.81 $653M 39.3M 216K -$2.64

ORIC Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 605,428 1,018,213
Revenue 0 0 0 0
EBITDA (80,500) (73,039) (27,252) (21,235)
Net Income (81,340) (73,703) (26,883) (21,363)
Total Assets 283,960 298,997 94,093 46,734
Total Debt 1,855 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ORIC Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ORIC Pharmaceuticals‘s full profile, request access.

Request a free trial

ORIC Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore ORIC Pharmaceuticals‘s full profile, request access.

Request a free trial

ORIC Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to count
Drug Discovery
South San Francisco, CA
66 As of 2021
00000
00000000 00000

0000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat n
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

0000 000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000 000000000
Redwood City, CA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ORIC Pharmaceuticals Competitors (70)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioAtla Formerly VC-backed San Diego, CA 00 00000 00000000 00000
0000 0000000000000 Venture Capital-Backed Redwood City, CA 00 00000 00000000 00000
00000 Formerly VC-backed South San Francisco, CA 000 00.000 00000000 00.000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 70 competitors. Get the full list »

ORIC Pharmaceuticals Executive Team (17)

Name Title Board Seat Contact Info
Jacob Chacko MD Chief Executive Officer & Board Member
Dominic Piscitelli Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Richard Heyman Ph.D Co-Founder, Chairman & Board Member
Scott Lowe Ph.D Co-Founder & Scientific Advisory Board Member
Charles Sawyers MD Scientific Co-Founder
You’re viewing 5 of 17 executive team members. Get the full list »

ORIC Pharmaceuticals Board Members (13)

Name Representing Role Since
Carl Gordon Ph.D OrbiMed Board Member 000 0000
Jacob Chacko MD ORIC Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Laurence Lasky Ph.D Self Board Member 000 0000
Leo Guthart Self Board Member 000 0000
Lori Kunkel MD Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

ORIC Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ORIC Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ORIC Pharmaceuticals‘s full profile, request access.

Request a free trial